Literature DB >> 26796771

Content validity of global measures for at-work productivity in patients with rheumatic diseases: an international qualitative study.

Sarah Leggett1, Antje van der Zee-Neuen2, Annelies Boonen2, Dorcas Beaton3, Mihai Bojinca4, Ailsa Bosworth5, Sabrina Dadoun6, Bruno Fautrel6, Sofia Hagel7, Catherine Hofstetter8, Diane Lacaille9, Denise Linton3, Carina Mihai4, Ingemar F Petersson10, Pam Rogers9, Carlo Sciré11, Suzanne M M Verstappen12.   

Abstract

OBJECTIVES: To identify from a patient's perspective, difficulties and differences in the comprehension of five global presenteeism measures in patients with inflammatory arthritis and OA across seven countries.
METHODS: Seventy patients with a diagnosis of inflammatory arthritis or OA in paid employment were recruited from seven countries across Europe and Canada. Patients were randomly allocated to be cognitively debriefed on 3/5 global measures [Work Productivity Scale - Rheumatoid Arthritis, Work Productivity and Activity Impairment Questionnaire (WPAI), Work Ability Index, Quality and Quantity questionnaire, and WHO Health and Work Performance Questionnaire (HPQ)], with the WPAI debriefed in all patients as a standard measure of comparison between countries and patients. NVivo was used to code the data into four themes: construct and anchor, time recall, reference frame, and attribution.
RESULTS: Discrepancies were found in the interpretation of the word performance (HPQ) between countries, with Romania and Sweden relating performance to sports rather than work. Seventy percent of patients considered that a 7-day recall (WPAI) can accurately represent how their disease affects work productivity. The compared to normal reference (Quality and Quantity questionnaire) was reportedly too ambiguous, and the comparison with colleagues (HPQ), made many feel uncomfortable. Overall, 29% of patients said the WPAI was the most relevant to them, making it the most favoured measure.
CONCLUSION: Overall, patients across countries agree that the construct of work productivity in the last 7 days can accurately reflect the impact of disease while at work. Some current constructs to assess at-work productivity are not interchangeable between languages.
© The Author 2016. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  cognitive debriefing interview; content validity; global measures; patient-reported outcomes; presenteeism; work productivity

Mesh:

Year:  2016        PMID: 26796771     DOI: 10.1093/rheumatology/kev435

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  7 in total

1.  Self-Reported Work Ability Predicts Rehabilitation Measures, Disability Pensions, Other Welfare Benefits, and Work Participation: Longitudinal Findings from a Sample of German Employees.

Authors:  Matthias Bethge; Katja Spanier; Elke Peters; Elliot Michel; Michael Radoschewski
Journal:  J Occup Rehabil       Date:  2018-09

Review 2.  Incorporating the patient's perspective in outcomes research.

Authors:  Betty Hsiao; Liana Fraenkel
Journal:  Curr Opin Rheumatol       Date:  2017-03       Impact factor: 5.006

3.  The importance of work participation as an outcome in rheumatology.

Authors:  Karen Walker-Bone; Carol Black
Journal:  Rheumatology (Oxford)       Date:  2016-04-11       Impact factor: 7.580

4.  Methodological aspects of design, analysis and reporting of studies with work participation as an outcome domain in patients with inflammatory arthritis: results of two systematic literature reviews informing EULAR points to consider.

Authors:  Mary Lucy Marques; Alessia Alunno; Sofia Ramiro; Polina Putrik; Annelies Boonen; Marieke M Ter Wee; Louise Falzon
Journal:  RMD Open       Date:  2021-02

5.  Large country differences in work outcomes in patients with RA - an analysis in the multinational study COMORA.

Authors:  Antje van der Zee-Neuen; Polina Putrik; Sofia Ramiro; Andras P Keszei; Ihsane Hmamouchi; Maxime Dougados; Annelies Boonen
Journal:  Arthritis Res Ther       Date:  2017-09-29       Impact factor: 5.156

6.  Predictors of presenteeism, absenteeism and job loss in patients commencing methotrexate or biologic therapy for rheumatoid arthritis.

Authors:  James M Gwinnutt; Sarah Leggett; Mark Lunt; Anne Barton; Kimme L Hyrich; Karen Walker-Bone; Suzanne M M Verstappen
Journal:  Rheumatology (Oxford)       Date:  2020-10-01       Impact factor: 7.580

7.  EULAR Points to Consider (PtC) for designing, analysing and reporting of studies with work participation as an outcome domain in patients with inflammatory arthritis.

Authors:  Annelies Boonen; Polina Putrik; Mary Lucy Marques; Alessia Alunno; Lydia Abasolo; Dorcas Beaton; Neil Betteridge; Mathilda Bjørk; Maarten Boers; Boryana Boteva; Bruno Fautrel; Francis Guillemin; Elsa F Mateus; Elena Nikiphorou; Márta Péntek; Fernando Pimentel Santos; Johannes L Severens; Suzanne M M Verstappen; Karen Walker-Bone; Johan Karlsson Wallman; Marieke M Ter Wee; René Westhovens; Sofia Ramiro
Journal:  Ann Rheum Dis       Date:  2021-04-08       Impact factor: 19.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.